ROUNDTABLE: Pfenex and Agila Biotech Biosimilars Joint Venture – The Convergence of Expression & Manufacturing Technology Harnessing the Emerging Market Opportunity

This podcast features:
Dr. Bertrand Liang, Chief Executive Officer, Pfenex Inc
Dr. Anand Iyer, Chief Executive Officer, Agila Biotech
Encik Rizatuddin “Ritz” Ramli, Chief Executive Officer, Malaysian Bio-XCell Sdn Bhd
Daniel Bauer, Commercial Executive, FlexFactory Facilities, Xcellerex, Inc, A GE Healthcare Company



This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting the development and manufacture of biotherapeutics.

The 2013 BioProcess Theater consisted of five main presentation tracks: Biosimilars, Single-Use Processing, Cell Therapy, Antibody/Non-Antibody Manufacturing, and Vaccine Manufacturing.

If you would like more information on these presentations, please email us:

Leave a Reply